Zymeworks (ZYME) Non Operating Income (2021 - 2026)
Zymeworks (ZYME) reported Non Operating Income of $120000.0 for Q1 2026, down 96.5% on a YoY basis from $3.4 million in Q1 2025, and down 99.12% sequentially from $13.6 million in Q4 2025.
Zymeworks (ZYME) Non Operating Income (2021 - 2026) Analysis & Trends
Zymeworks (ZYME) has 6 years of Non Operating Income data on file, last reported at $120000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 96.5% year-over-year to $120000.0; the trailing twelve-month figure through Mar 2026 stood at $13.4 million (down 41.78% YoY), and the FY2025 full-year result was $13.4 million, down 33.03% from the prior year.
- Non Operating Income declined to $120000.0 in Q1 2026, from $13.6 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $19.8 million in Q4 2023 to a low of -$692000.0 in Q4 2022.
- A 5-year average of $3.6 million and a median of $304000.0 in 2024 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income surged 2956.5% in 2023 and tumbled 644.74% in 2025, its largest moves.
- Tracing ZYME's Non Operating Income over 5 years: stood at -$692000.0 in 2022, then surged by 2956.5% to $19.8 million in 2023, then retreated by 0.2% to $19.7 million in 2024, then sank by 31.0% to $13.6 million in 2025, then tumbled by 99.12% to $120000.0 in 2026.
- Business Quant data shows ZYME's Non Operating Income at $120000.0 in Q1 2026, $13.6 million in Q4 2025, and $315000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Zymeworks | 1.70 Bn | 1.34 Bn | - | 120,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120,000.00 |
| Dec 31, 2025 | 13.61 Mn |
| Sep 30, 2025 | 315,000.00 |
| Jun 30, 2025 | -621,000.00 |
| Mar 31, 2025 | 3.42 Mn |
| Dec 31, 2024 | 19.73 Mn |
| Sep 30, 2024 | -204,000.00 |
| Jun 30, 2024 | 114,000.00 |
| Mar 31, 2024 | 304,000.00 |
| Dec 31, 2023 | 19.77 Mn |
| Sep 30, 2023 | 5.03 Mn |
| Jun 30, 2023 | -209,000.00 |
| Mar 31, 2023 | -487,000.00 |
| Dec 31, 2022 | -692,000.00 |
| Sep 30, 2022 | 1.36 Mn |
| Jun 30, 2022 | 759,000.00 |
| Mar 31, 2022 | -315,000.00 |
| Dec 31, 2021 | -1.64 Mn |
| Sep 30, 2021 | 1.15 Mn |